4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-16-151477
CIK 0001305253operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:11 PM ET
Size
10.5 KB
Accession
0001209191-16-151477
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2016-11-18$12.90/sh+460$5,934→ 460 total(indirect: By son) - Purchase
Common Stock
2016-11-17$12.73/sh+15,000$190,950→ 16,355 total
Holdings
- 151,064(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:11 PM ET
- Size
- 10.5 KB